Abstract
Trisomy 18 (T18) remains the second most common aneuploidy. It is associated with multiple congenital anomalies and causes intrauterine fetal demise in the most severe cases.
Objectives: To examine the screening performance of ultrasound-based protocols for detecting T18, we aimed to determine the most common signs and their prevalence in fetuses with T18 to develop logistic regression model.
Methods: This was a prospective study based on singleton pregnancies examined at gestation 11+0 to 13+6. The referrals constituted 6210 patients. Scan protocol enclosed a systematic review of the entire early fetal anatomy, including fetal cardiac evaluation and sonographic signs of aneuploidy.
Results: Our study population comprised 5650 pregnancies: 5613 cases with a normal karyotype and 37 cases with T18. The mean nuchal translucency (NT) thickness in the subgroup of euploidy was 1.7 and in the subgroup of T18 it was 5.4. No statistically significant differences were found in terms of maternal age. One case of T18 (2.7%) demonstrated no markers of aneuploidy as opposed to 5111 cases of euploidy (91.1%). Extracardiac malformations were identified in 13 cases of T18 (35.1%) and in 48 cases of euploidy (0.8%). Congenital heart defects were observed in 26 cases of T18 (70.3%) and in 27 cases of euploidy (0.5%).
Conclusions: Our results showed good screening performance of ultrasound-based risk calculation models. When the first trimester pattern of T18 is considered, an increased NT, tricuspid regurgitation, single umbilical artery, omphalocele and right dominant heart should be specifically searched for.
References
[1] Tonks AM, Gornall AS, Larkins SA, Gardosi JO. Trisomies 18 and 13: trends in prevalence and prenatal diagnosis-population based study. Prenat Diagn. 2013;33:742–50.10.1002/pd.4117Search in Google Scholar
[2] Tongsong T, Sirichotiyakul S, Wanapirak C, Chanprapaph P. Sonographic features of trisomy 18 at midpregnancy. J Obstet Gynaecol Res. 2002;28:245–50.10.1046/j.1341-8076.2002.00053.xSearch in Google Scholar
[3] Nyberg DA, Kramer D, Resta RG, Kapur R, Mahony BS, Luthy DA, et al. Prenatal sonographic findings of trisomy 18: review of 47 cases. J Ultrasound Med. 993;12:103–13.10.7863/jum.1993.12.2.103Search in Google Scholar
[4] Bronsteen R, Lee W, Vettraino IM, Huang R, Comstock CH. Second-trimester sonography and trisomy 18. J Ultrasound Med. 2004;23:233–40.10.7863/jum.2004.23.2.233Search in Google Scholar
[5] Watson WJ, Miller RC, Wax JR, Hansen WF, Yamamura Y, Polzin WJ. Sonographic findings of trisomy 18 in the second trimester of pregnancy. J Ultrasound Med. 2008;27:1033–8.10.7863/jum.2008.27.7.1033Search in Google Scholar
[6] Papp C, Ban Z, Szigeti Z, Csaba A, Beke A, Papp Z. Role of second trimester sonography in detecting trisomy 18: a review of 70 cases. J Clin Ultrasound. 2007;35:68–72.10.1002/jcu.20290Search in Google Scholar
[7] Sepulveda W, Wong AE, Dezerega V. First-trimester sonographic findings in trisomy 18: a review of 53 cases. Prenat Diagn. 2010;30:256–9.10.1002/pd.2462Search in Google Scholar
[8] Sherod C, Sebire NJ, Soares W, Snijders RJ, Nicolaides KH. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan. Ultrasound Obstet Gynecol. 1997;10:387–90.10.1046/j.1469-0705.1997.10060387.xSearch in Google Scholar
[9] Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;191:45–67.10.1016/j.ajog.2004.03.090Search in Google Scholar
[10] Kagan KO, Wright D, Maiz N, Pandeva I, Nicolaides KH. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;32:488–92.10.1002/uog.6123Search in Google Scholar
[11] Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med. 2005;353:2001–11.10.1056/NEJMoa043693Search in Google Scholar
[12] Tul N, Spencer K, Noble P, Chan C, Nicolaides K. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn. 1999;19:1035–42.10.1002/(SICI)1097-0223(199911)19:11<1035::AID-PD694>3.0.CO;2-2Search in Google Scholar
[13] Spencer K, Nicolaides KH. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn. 2002;22:877–9.10.1002/pd.420Search in Google Scholar
[14] Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, et al. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol. 2007;110:651–7.10.1097/01.AOG.0000278570.76392.a6Search in Google Scholar
[15] Ghaffari SR, Tahmasebpour AR, Jamal A, Hantoushzadeh S, Eslamian L, Marsoosi V, et al. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study. Ultrasound Obstet Gynecol. 2012;39:528–34.10.1002/uog.10051Search in Google Scholar
[16] Karadzov-Orlic N, Egic A, Milavanovic Z, Marinkovic M, Damnjanovic-Pazin B, Lukic R, et al. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome. Prenat Diagn. 2012;32:638–43.10.1002/pd.3873Search in Google Scholar
[17] Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31:7–15.10.1002/pd.2637Search in Google Scholar
[18] American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of obstetric ultrasound examinations. J Ultrasound Med. 2010;29:157–66.10.7863/jum.2010.29.1.157Search in Google Scholar
[19] Fetal Echocardiography Task Force; American Institute of Ultrasound in Medicine Clinical Standards Committee; American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. AIUM practice guideline for the performance of fetal echocardiography. J Ultrasound Med. 2011;30:127–36.10.7863/jum.2011.30.1.127Search in Google Scholar
[20] Volpe P, De Robertis V, Campobasso G, Tempesta A, Volpe G, Rembouskos G. Diagnosis of congenital heart disease by early and second-trimester fetal echocardiography. J Ultrasound Med. 2012;31:563–8.10.7863/jum.2012.31.4.563Search in Google Scholar
[21] Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free betahuman chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 2008;31:618–24.10.1002/uog.5331Search in Google Scholar
[22] Wright D, Spencer K, Kagan KO, Tørring N, Petersen OB, Christou A, et al. First-trimester combined screening for trisomy 21 at 7–14 weeks gestation. Ultrasound Obstet Gynecol. 2010;36:404–11.10.1002/uog.7755Search in Google Scholar
[23] Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimalgestational ages. An interventional study. Prenat Diagn. 2004;24:541–5.10.1002/pd.949Search in Google Scholar
[24] Yang JH, Chung JH, Shin JS, Choi JS, Ryu HM, Kim MY. Prenatal diagnosis of trisomy 18: report of 30 cases. Prenat Diagn. 2005;25:119–22.10.1002/pd.1073Search in Google Scholar
[25] Lai S, Lau WL, Leung WC, Lai FK, Chin R. Is ultrasound alone enough for prenatal screening of trisomy 18? A single centre experience in 69 cases over 10 years. Prenat Diagn. 2010;30:1094–9.10.1002/pd.2623Search in Google Scholar
[26] Yeo L, Guzman ER, Day-Salvatore D, Walters C, Chavez D, Vintzileos AM. Prenatal detection of fetal trisomy 18 through abnormal sonographic features. J Ultrasound Med. 2003;22:581–90.10.7863/jum.2003.22.6.581Search in Google Scholar
[27] Wimalasundera RC, Gardiner HM. Congenital heart disease and aneuploidy. Prenat Diagn. 2004;24:1116–22.10.1002/pd.1068Search in Google Scholar
[28] Cheng P-J, Liu C-M, Chueh H-Y, Lin C-M, Soong Y-K. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18. Prenat Diagn. 2003;23:248–51.10.1002/pd.581Search in Google Scholar
[29] Moyano D, Huggon IC, Allan LD. Fetal echocardiography in trisomy 18. Arch Dis Child Fetal Neonatal Ed. 2005;90:F520–2.10.1136/adc.2004.070342Search in Google Scholar
[30] Liao AW, Snijders R, Geerts L, Spencer K, Nicolaides KH. Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol. 2000;16:610–13.10.1046/j.1469-0705.2000.00292.xSearch in Google Scholar
[31] Rembouskos G, Cicero S, Longo D, Sacchini C, Nicolaides KH. Single umbilical artery at 11-14 weeks’ gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol. 2003;22:567–70.10.1002/uog.901Search in Google Scholar
[32] Blaas HG, Eik-Nes SH, Kiserud T, Hellevik LR. Early development of the abdominal wall, stomach and heart from 7 to 12 weeks of gestation: a longitudinal ultrasound study. Ultrasound Obstet Gynecol. 1995;6:240–9.10.1046/j.1469-0705.1995.06040240.xSearch in Google Scholar
[33] Khalil A, Arnaoutoglou C, Pacilli M, Szabo A, David AL, Pandya P. Outcome of fetal exomphalos diagnosed at 11-14 weeks of gestation. Ultrasound Obstet Gynecol. 2012;39:401–6.10.1002/uog.10048Search in Google Scholar
[34] Rice KJ, Ballas J, Lai E, Hartney C, Jones MC, Pretorius DH. Diagnosis of fetal limb abnormalities before 15 weeks: cause for concern. J Ultrasound Med. 2011;30:1009–19.10.7863/jum.2011.30.7.1009Search in Google Scholar
[35] Baken L, Benoit B, Koning AH, Willemsen SP, van der Spek PJ, Steegers-Theunissen RP, et al. First-trimester hand measurements in euploid and aneuploid human fetuses using virtual reality. Prenat Diagn. 2014;34:961–9.10.1002/pd.4404Search in Google Scholar
[36] Quintero RA, Johnson MP, Mendoza G, Evans MI. Ontogeny of clenched-hand development in trisomy 18 fetuses: a serial transabdominal fetoscopic observation. Fetal Diagn Ther. 1999;14:68–70.10.1159/000020892Search in Google Scholar
The authors stated that there are no conflicts of interest regarding the publication of this article.
©2016 by De Gruyter